Tamoxifen and ovarian cysts: A prospective study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 100, Issue 1, 2001, Pages 77-80

  Seoud, Muhieddine ^a   El saghir, Naji ^a   Salem, Ziad ^a   Shamseddine, Ali ^a   Awwad, Johnny ^a   Medawar, Walid ^a   Khalil, Ali ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Breast cancer; Ovarian cysts; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTADENOMA; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CYST; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0035842356     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00445-6     Document Type: Article

References (32)

1. Tamoxifen and chemotherapy for lymph node negative, estrogen receptor positive breast cancer
2. The initial results from NSABP protocol P-1: A clinical trial to determine the worth of tamoxifen for preventing breast cancer in women at increased risk
3. Gynecological effect of tamoxifen and the association with endometrial cancer
4. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
5. Gynecologic tumors in tamoxifen-treated women with breast cancer
6. Ovarian cysts in pre-menopausal and post-menopausal tamoxifen-treated women with breast cancer
7. Effects of tamoxifen on uterus and ovaries of post-menopausal women in a randomised breast cancer prevention trial
8. A retrospective study of gynecologic complications associated with tamoxifen therapy in breast cancer patients
9. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse
10. Tamoxifen increases plasma estrogen-binding equivalents and has an estradiol agonistic effect on histologically normal pre-menopausal and post-menopausal endometrium
11. Endocrine status of pre-menopausal node-positive breast cancer patients following adjuvant chemotherapy and long term tamoxifen
12. Role and mechanism of action of tamoxifen in pre-menopausal women with metastatic breast carcinoma
13. Effect of the anti-estrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, estradiol and progesterone in normal pre-menopausal women
14. A comparison of the effects of clomiphene and tamoxifen treatment on the concentration of estardiol and progesterone in the peripheral plasma of infertile women
15. New synthetic agents for the induction of ovulation: Preliminary trials in women
16. Induction of ovulation by tamoxifen
17. The effects of tamoxifen on endometrial insulin-like growth factor-1 expression
18. Tamoxifen: As an alternative approach in clomiphene resistant polycystic ovarian syndrome patients
19. Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a pre-menopausal woman: A case report
20. Rapid growth of a leimyoma in a patient receiving tamoxifen
21. A follicular cyst during tamoxifen therapy in a pre-menopausal breast cancer woman
22. Adverse effects of tamoxifen on the female genital tract
23. Ovarian torsion in a pre-menopausal woman treated with tamoxifen for breast cancer
24. Tamoxifen treatment in pre-menopausal breast cancer patient may be associated with ovarian hyperstimulation
25. Endometriod adenocarcinoma of the ovary and long term tamoxifen therapy: A coincidence or a cause for concern
26. Granulosa cell tumor of the ovary associated with antecedent tamoxifen use
27. Ovarian tumors in a cohort of infertile women
28. Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breats cancer
29. Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer
30. Ambigous genitalia in infant exposed to tamoxifen in-utero
31. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives